Cancer Research UK-funded research

Chemotherapy-induced peripheral neuropathy is caused by cancer treatment, but doctors don’t have a way to treat it. Our research is changing that.

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.

Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place.

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we’re to run trials like it again. 

Teenagers and young adults with cancer have to deal with unique challenges. We’re using our expertise to help tackle them.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

Olaparib, a targeted cancer drug discovered and developed with our funding, has been approved for hundreds of patients with certain breast and prostate cancers in England. 

In her final weeks, fuelled by her spirit of ‘rebellious hope’ and passion to help others, Deborah worked to establish the Bowelbabe Fund for Cancer Research UK, to support projects she was passionate about. Today the initial projects to receive funding from the Bowelbabe Fund have been announced.

We’re helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.